Riskpilot← Back to searchSign inGet full accessSKINLAB TROMSØ AS
ASActiveOrg 930185523Grønnegata 62, 9008 TromsøOther human health activities n.e.c. · NACE 8699Est. 20221 employees
Revenue 2025
NOK 1,6M
+37% vs 2024
EBITDA margin
0.6%
+107% vs 2024
Equity ratio
27.1%
Financial strength
Net profit 2025
NOK 5K
+103% vs 2024
| Revenue | NOK 1,6M | +37% |
| EBITDA | NOK 11K | +107% |
| Net profit | NOK 5K | +103% |
| Total assets | NOK 482K | +0% |
| Equity | NOK 131K | +4% |
| Employees | 1 | — |
Legal name
SKINLAB TROMSØ AS
Org number
930185523
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
8. november 2022
Share capital
NOK 248 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drive helse- og skjønnhetstjenester, utleie til helsevirksomhet og eksterne oppdrag som undervisning og foredrag, samt det som naturlig tilhører dette.
Address
Grønnegata 62, 9008 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 43 | 1 147 | 1 206 | 1 646 |
| Staff expenses | −0 | −435 | −336 | −558 |
| EBITDA | −29 | 68 | −153 | 11 |
| Depreciation & amort. | −0 | −0 | −0 | −5 |
| EBIT | −29 | 68 | −153 | 6 |
| Net financials | 0 | 0 | 1 | −1 |
| Profit before tax | −29 | 68 | −153 | 5 |
| Tax | −0 | 9 | −0 | −0 |
| Net profit | −29 | 60 | −153 | 5 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 415 | 555 | 481 | 482 |
| Equity | 219 | 279 | 126 | 131 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 196 | 277 | 355 | 189 |
| Total debt | 196 | 277 | 355 | 351 |
EBITDA margin
0.6%
This company
15.8%
Market median
-96% vs market
20222025
Equity ratio
27.1%
This company
38.2%
Market median
-29% vs market
20222025
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20222025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20222025
Asset turnover
3.41×
This company
1.12×
Market median
+204% vs market
20222025
Debt / equity
2.68×
This company
0.62×
Market median
-332% vs market
20222025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 19.35% | 19.35% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Clavicula As
SKINLAB TROMSØ AS Board members of SKINLAB TROMSØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Evensen | Chief Executive Officer | 0 companies |
| Andre Fagerborg | Board of Directors | 0 companies |
| Sigurd Vorren | Deputy Chairman | 0 companies |